Clinical Trial Update: Pegylated Liposomal Doxorubicin Versus Daunorubicin to Treat Acute Lymphoblastic Leukemia: [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing pegylated liposomal doxorubicin with daunorubicin for acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Daunorubicin (daunorubicin)
• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)

Snippet

Sponsor: Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd. | Conditions: Acute Lymphoblastic Leukemia | Phase 3 | Status: UNKNOWN